128 related articles for article (PubMed ID: 17998717)
1. Bone metastasis from ovarian cancer.
Tiwari A; Kumar N; Bajpai R; Lal P
J Cancer Res Ther; 2007; 3(1):34-6. PubMed ID: 17998717
[TBL] [Abstract][Full Text] [Related]
2. Borderline mucinous tumour with mural nodule of signet ring adenocarcinoma.
Ong NC; Ostör AG
Aust N Z J Obstet Gynaecol; 2002 Nov; 42(5):561-2. PubMed ID: 12495115
[No Abstract] [Full Text] [Related]
3. Bad Disease with Reasonable Outcome.
Osmani AH; Suleman K
J Coll Physicians Surg Pak; 2019 Aug; 29(8):794-795. PubMed ID: 31358111
[No Abstract] [Full Text] [Related]
4. Breast Metastases Secondary to Primary Pancreatic Mucinous Cystadenocarcinoma: A Case Report.
Chan KS; Ang WW; Chuah KL; Shelat VG
Pancreas; 2021 Jan; 50(1):e5-e6. PubMed ID: 33370036
[No Abstract] [Full Text] [Related]
5. Rare case of stage IA epithelial ovarian cancer with bone as the first site of recurrent metastasis.
Chang KH; Lee JP; Ryu HS
Int J Gynecol Cancer; 2006; 16 Suppl 1():322-6. PubMed ID: 16515614
[TBL] [Abstract][Full Text] [Related]
6. [Recurrence of ovarian cancer in extraperitoneal localization after 29th years of radical surgery].
Jamroz A; Rudzki S; Walczyna B
Pol Merkur Lekarski; 2005 Oct; 19(112):545-7. PubMed ID: 16379322
[TBL] [Abstract][Full Text] [Related]
7. Secondary acute nonlymphocytic leukemia following successful chemotherapy combining cisplatin, doxorubicin, and cyclophosphamide for stage IV epithelial ovarian cancer.
Yokoyama Y; Futagami M; Fukushi Y; Sakamoto T; Higuchi T; Fujii S; Sato S; Takami H; Saito Y
Arch Gynecol Obstet; 2000 Apr; 263(4):206-7. PubMed ID: 10834334
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study of topotecan and cisplatin as first line chemotherapy in epithelial ovarian cancer].
Meng LH; Kong BH; Zhang YZ; Yang XS; Wang LJ; Su SL; Jiang J; Cui BX; Wang B
Zhonghua Fu Chan Ke Za Zhi; 2007 Oct; 42(10):683-7. PubMed ID: 18241544
[TBL] [Abstract][Full Text] [Related]
9. [Granulosa cell tumor with liver metastasis treated with partial hepatectomy and chemotherapy. Report of a case].
Ayala Garza P; García-Compeán D; Barragán Villarreal RF; Escobedo Villarreal M; González Guerrero JF; de la Peña Hinojosa C; Barboza Quintana O; Guzmán Garza FJ
Rev Gastroenterol Mex; 1992; 57(3):179-82. PubMed ID: 1284981
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: a Gynecologic Oncology Group study.
Armstrong DK; Bookman MA; McGuire W; Bristow RE; Schilder JM;
Gynecol Oncol; 2007 Jun; 105(3):667-71. PubMed ID: 17368526
[TBL] [Abstract][Full Text] [Related]
11. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
Pisano C; Greggi S; Tambaro R; Losito S; Iodice F; Di Maio M; Ferrari E; Falanga M; Formato R; Iaffaioli VR; Pignata S
Anticancer Res; 2005; 25(5):3501-5. PubMed ID: 16101169
[TBL] [Abstract][Full Text] [Related]
12. Phase I and pharmacologic study of the combination of paclitaxel, cisplatin, and topotecan administered intravenously every 21 days as first-line therapy in patients with advanced ovarian cancer.
Herben VM; Panday VR; Richel DJ; Schellens JH; van der Vange N; Rosing H; Beusenberg FD; Hearn S; Doyle E; Beijnen JH; ten Bokkel Huinink WW
J Clin Oncol; 1999 Mar; 17(3):747-55. PubMed ID: 10071262
[TBL] [Abstract][Full Text] [Related]
13. Back to the future: multiagent chemotherapy in ovarian cancer revisited.
Cannistra SA
J Clin Oncol; 1999 Mar; 17(3):741-3. PubMed ID: 10071260
[No Abstract] [Full Text] [Related]
14. Complete response of a stage IV mucinous cystadenocarcinoma of the ovary to systemic chemotherapy employing paclitaxel and carboplatin.
Yokoyama Y; Kaji H; Kondoh H; Takeuchi E; Yamasaki Y; Inui Y
Gynecol Obstet Invest; 2001; 52(3):210-4. PubMed ID: 11598367
[TBL] [Abstract][Full Text] [Related]
15. Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel.
Hoskins P; Vergote I; Cervantes A; Tu D; Stuart G; Zola P; Poveda A; Provencher D; Katsaros D; Ojeda B; Ghatage P; Grimshaw R; Casado A; Elit L; Mendiola C; Sugimoto A; D'Hondt V; Oza A; Germa JR; Roy M; Brotto L; Chen D; Eisenhauer EA
J Natl Cancer Inst; 2010 Oct; 102(20):1547-56. PubMed ID: 20937992
[TBL] [Abstract][Full Text] [Related]
16. Gingival metastasis from ovarian mucinous cystadenocarcinoma as an initial manifestation (a rare case report).
Sasaki H; Ohara N; Minamikawa T; Umeda M; Komori T; Kojima N; Takemura N; Morita H; Sugihara R; Enoki E; Itoh T
Kobe J Med Sci; 2008 Aug; 54(3):E174-82. PubMed ID: 19246966
[TBL] [Abstract][Full Text] [Related]
17. Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group Study.
Hoskins P; Eisenhauer E; Vergote I; Dubuc-Lissoir J; Fisher B; Grimshaw R; Oza A; Plante M; Stuart G; Vermorken J
J Clin Oncol; 2000 Dec; 18(24):4038-44. PubMed ID: 11118464
[TBL] [Abstract][Full Text] [Related]
18. [Treatment and prognostic factors of epithelial ovarian cancer].
Wei L; Qian H; Li W
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):476-9. PubMed ID: 9639741
[TBL] [Abstract][Full Text] [Related]
19. Remarkable response of primary squamous cell carcinoma of the ovary to paclitaxel and cisplatin.
Eltabbakh GH; Hempling RE; Recio FO; O'Neill CP
Obstet Gynecol; 1998 May; 91(5 Pt 2):844-6. PubMed ID: 9572185
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literature.
Serkies K; Węgrzynowicz E; Jassem J
Arch Gynecol Obstet; 2011 Mar; 283 Suppl 1(Suppl 1):97-100. PubMed ID: 21369726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
